Pancreatic Neoplasms
Showing NaN - NaN of 10
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- LY3537982
- +7 more
-
Los Angeles, California
- +21 more
Jul 22, 2022
Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville
Active, not recruiting
- Pancreatic Cancer
- +3 more
- anti-EGFR-bispecific antibody armed activated T-cells
-
New York, New York
- +1 more
Oct 7, 2021
Pancreatic Cyst, Pancreatic Tumors, Pancreatic Adenoma Trial in United States (Endoscopic ultrasound fine needle aspiration)
Completed
- Pancreatic Cyst
- +7 more
- Endoscopic ultrasound fine needle aspiration
-
Atlanta, Georgia
- +3 more
Aug 28, 2017
Pancreatic Tumors Trial in United Kingdom, United States (KU-0059436 (AZD2281)(PARP inhibitor), Gemcitabine)
Completed
- Pancreatic Neoplasms
- KU-0059436 (AZD2281)(PARP inhibitor)
- Gemcitabine
-
New York, New York
- +3 more
Dec 19, 2013
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013
Pancreatic Tumors Trial in New York (gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin)
Completed
- Pancreatic Neoplasms
- gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin
-
New York, New YorkSt. Luke's-Roosevelt Hospital Center
Aug 14, 2009
Pancreatic Tumors, Pain Trial in New York (Acupuncture)
Completed
- Pancreatic Neoplasms
- Pain
- Acupuncture
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 7, 2006